title: Steady remission of scleromyxedema 3 years after autologous stem cell transplantation: an in vivo and in vitro study.
authors.forename: Isabel
authors.initials: I
authors.lastname: Illa
authors.forename: Carolina
authors.initials: C
authors.lastname: de la Torre
authors.forename: Ricardo
authors.initials: R
authors.lastname: Rojas-Garcia
authors.forename: Antoni
authors.initials: A
authors.lastname: Altes
authors.forename: Rafael
authors.initials: R
authors.lastname: Blesa
authors.forename: Jordi
authors.initials: J
authors.lastname: Sierra
authors.forename: Eduard
authors.initials: E
authors.lastname: Gallardo
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003240:Connective Tissue Diseases / Q000628:therapy; D018572:Disease-Free Survival; D005347:Fibroblasts / Q000737:chemistry; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D009230:Myxedema / Q000628:therapy*; D011506:Proteins / Q000032:analysis; D012074:Remission Induction; D014182:Transplantation, Autologous
chemical_list: D011506:Proteins